Prof. emeritus, Dr. rer. nat. Florian Wurm

ExcellGene SA Monthey, Valais, Switzerland Swiss Federal Institute of Technology Lausanne (EPFL), Life Science Faculty, Lausanne
Switzerland
Florian M. Wurm, trained as Biologist/Molecular Geneticist (University of Giessen, PhD 1980). His career involved academic and industrial work: Behringwerke AG, Marburg (1981-1984), Harvard Medical School, Boston (1984-1985), Genentech Inc, San Francisco (1986-1995), Swiss Federal Institute of Technology, Lausanne (EPFL), (1995-2015), ExcellGene SA, Monthey, Switzerland (2001-today). He contributed to the generation of several high-value therapeutic products (cumulatively now sold for multibillion Dollars/year globally). His research activities covered Process Sciences, from DNA to large-scale manufacturing, using recombinant animal cells (CHO, HEK and others) in bioreactors. He is/was founder (2001), CSO (2002-today, CEO (2015-2016) and CSO/Chairman (since 2017) of ExcellGene SA, a familyowned service company for the Pharmaceutical Industry. He retired from the EPFL in 2015. Florian is member and was Chairman of the European Society of Animal Cell Technology (ESACT). He has published, with co-workers, more than 230 highly referenced papers and filed more than 30 patents covering aspects of expression and manufacture of clinical proteins using mammalian cells in bioreactors.

Events/Masterclasses Prof. emeritus, Dr. rer. nat. Florian Wurm is currently speaking at

No events currently available.

Are you interested in a custom-made event with this trainer?

Contact us to Request more information about your custom-made Corporate Learning program.

REQUEST MORE INFORMATION

Prof. emeritus, Dr. rer. nat. Florian Wurm
ExcellGene SA Monthey, Valais, Switzerland Swiss Federal Institute of Technology Lausanne (EPFL), Life Science Faculty, Lausanne
Switzerland
Florian M. Wurm, trained as Biologist/Molecular Geneticist (University of Giessen, PhD 1980). His career involved academic and industrial work: Behringwerke AG, Marburg (1981-1984), Harvard Medical School, Boston (1984-1985), Genentech Inc, San Francisco (1986-1995), Swiss Federal Institute of Technology, Lausanne (EPFL), (1995-2015), ExcellGene SA, Monthey, Switzerland (2001-today). He contributed to the generation of several high-value therapeutic products (cumulatively now sold for multibillion Dollars/year globally). His research activities covered Process Sciences, from DNA to large-scale manufacturing, using recombinant animal cells (CHO, HEK and others) in bioreactors. He is/was founder (2001), CSO (2002-today, CEO (2015-2016) and CSO/Chairman (since 2017) of ExcellGene SA, a familyowned service company for the Pharmaceutical Industry. He retired from the EPFL in 2015. Florian is member and was Chairman of the European Society of Animal Cell Technology (ESACT). He has published, with co-workers, more than 230 highly referenced papers and filed more than 30 patents covering aspects of expression and manufacture of clinical proteins using mammalian cells in bioreactors.
Prof. emeritus, Dr. rer. nat. Florian Wurm
Description